Compare ARK Genomic Revolution ETF (ARKG) vs Boeing Co (BA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Boeing Co — how do they compare? ARK Genomic Revolution ETF trades at $40.91, while Boeing Co trades at $219.49 (market cap $175.22B). The key difference: Boeing Co pays a 0.03% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, Boeing Co nearer its low. Which is the better fit depends on your goals.
| ARKG | BA | |
|---|---|---|
Sector | Sector/Thematic | Industrials |
52-Week High | $43.57 | $252.15 |
52-Week Low | $23.09 | $179.12 |
Market Cap | — | $175.22B |
Volume | — | 7,591,579 |
Enterprise Value | — | $201.53B |
Dividend Yield | — | 0.03% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Boeing (BA) trades at $222.28, down 0.37% on the day, with a bullish technical signal and strong analyst support. The stock shows improving fundamentals with 2025 revenue of $89.46B and net income of $2.24B, reversing previous losses. Recent news includes both positive developments like new aircraft orders and regulatory milestones, alongside ongoing safety concerns highlighted by recent incidents.
The outlook is cautiously optimistic with a $268.33 consensus price target representing 21% upside. Key opportunities include production expansion and defense contracts, while risks center on operational execution, debt burden, and persistent safety-related headline volatility that could impact investor confidence and regulatory timelines.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Boeing Co
The Boeing Company, together with its subsidiaries, develops, produces, and markets commercial jet aircraft, as well as provides related support services to the commercial airline industry worldwide. The Company also researches, develops, produces, modifies, and supports information, space, and defense systems, including military aircraft, helicopters and space and missile systems.
Read more on BA →
